Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06607731
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-26
Brief Title:
Percutaneous Gelled Alcohol Sclerotherapy for Aggressive Angiomas Evaluation of Feasibility Safety and Efficacy
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Percutaneous Gelled Alcohol Sclerotherapy for Aggressive Angiomas Evaluation of Feasibility Safety and Efficacy
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators aimed to evaluate efficacy and safety of a non-surgical protocol treatment combining transarterial embolization and percutaneous radiopaque gelled ethanol RGE sclerotherapy in a first procedure then followed by vertebroplasty in a second procedure to treat aggressive vertebral hemangioma patients in tertiary hospital Exclusion criteria were age 18-years old and any association with neurological deficit
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None